Sinolink Securities Co.Ltd(600109) on August 24, the research report said that the first purchase rating of Sinocelltech Group Limited(688520) (688520. Sh, latest price: 61.7 yuan) was given. The reasons for rating mainly include: 1) track: Global bioengineering Toread Holdings Group Co.Ltd(300005) , which has accumulated a lot in just needed, heavy and high barrier drugs; 2) Heavyweight products: a 10 billion peak heavyweight drug that reorganizes eight factors to save thousands of people from death and disability; 3) Future space: heavyweight products, 14 price HPV, the world’s leading, technical support and sustainable growth. Risk warning: there is a risk that the progress of the pipeline under research does not meet the expected risk. The commercialization process does not meet expectations and competition intensifies the risk. Eight factors: the risk that the sales are lower than expected due to the high product price. Increase the risk of failure. Risk of lifting the ban on restricted shares.
AI comments: Sinocelltech Group Limited(688520) in the past month, it has received the attention of one Research Report of securities companies and bought one. The average target price is 70.7 yuan, 9 yuan higher than the latest price of 61.7 yuan, and the average target price has increased by 14.59%.
(Daily Economic News)
